Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-3-21
pubmed:abstractText
Bradykinin (BK) stimulates bone resorption in vitro and synergistically potentiates interleukin-1 (IL-1)-induced bone resorption and prostaglandin (PG) formation, suggesting that kinins are important in inflammation-induced bone loss. The present study was undertaken to study 1) the role of the kinin B1 and B2 receptors in the synergistic interaction with IL-1 and tumor necrosis factor alpha (TNFalpha), 2) the molecular mechanisms involved in synergistic enhancement of PG formation, and 3) the effects of kinins on cytokine-induced expression of RANKL, RANK, and osteoprotegerin (OPG) (the latter being crucial molecules in osteoclast differentiation).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1beta, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase..., http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Osteoprotegerin, http://linkedlifedata.com/resource/pubmed/chemical/RANK Ligand, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Bradykinin B1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Bradykinin B2, http://linkedlifedata.com/resource/pubmed/chemical/Receptor Activator of Nuclear..., http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
910-23
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17328065-Animals, pubmed-meshheading:17328065-Bradykinin, pubmed-meshheading:17328065-Cell Line, Tumor, pubmed-meshheading:17328065-Cells, Cultured, pubmed-meshheading:17328065-Cyclooxygenase 2, pubmed-meshheading:17328065-Cytokines, pubmed-meshheading:17328065-Dinoprostone, pubmed-meshheading:17328065-Humans, pubmed-meshheading:17328065-Interleukin-1beta, pubmed-meshheading:17328065-Mice, pubmed-meshheading:17328065-Mice, Inbred Strains, pubmed-meshheading:17328065-Mitogen-Activated Protein Kinase Kinases, pubmed-meshheading:17328065-NF-kappa B, pubmed-meshheading:17328065-Osteoblasts, pubmed-meshheading:17328065-Osteoprotegerin, pubmed-meshheading:17328065-RANK Ligand, pubmed-meshheading:17328065-RNA, Messenger, pubmed-meshheading:17328065-Receptor, Bradykinin B1, pubmed-meshheading:17328065-Receptor, Bradykinin B2, pubmed-meshheading:17328065-Receptor Activator of Nuclear Factor-kappa B, pubmed-meshheading:17328065-Tumor Necrosis Factor-alpha
pubmed:year
2007
pubmed:articleTitle
Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
pubmed:affiliation
Umeå University, Umeå, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't